Cancer mortality in Inner Mongolia of China, 2008-2010

HTML  Download Download as PDF (Size: 1165KB)  PP. 14-18  
DOI: 10.4236/ojepi.2014.41003    3,432 Downloads   5,409 Views  Citations

ABSTRACT

Objective: The aim of our study was to determine the status of the common cancer in Inner Mongolia of China. Methods: We obtained data from the Centers for Disease Control in the Inner Mongolia from five monitoring points of DRS in Inner Mongolia from 2008 to 2010. We calculated the crude mortality, the proportion of all cause of death during the three years, further calculated cancer mortality, the proportion of cancer death and PYLL by genders. Results: During the period 2008-2010, the crude mortality of all cause of death is 518.02 per million in Inner Mongolia. As the second most common cause of death, the mortality dying from cancer is 127.11 per million, accounting for over one fifth of all deaths. Among all deaths from cancer, the lung cancer had the highest mortality rates (46.25 per million in males and 17.95 per million in females) and PYLL (0.72 in males and 0.41 in females), followed by the liver cancer (23.76 per million) and the gastric cancer (16.15 per million). The female breast cancer is the fourth leading cancer from mortality and PYLL for 7.65 per million and 0.17. Conclusion: Our analysis determined the severity of cancer death in Inner Mongolia of China from 2008 to 2010.Our study found that the cancer mortality in Inner Mongolia is lower than Chinese average level and most west countries, higher than some Africa countries. Our results will guide future cancer control strategies in Inner Mongolia of China.

Share and Cite:

Yang, Y. , Zuo, F. , Du, M. , Liu, Z. , Li, Z. , Guo, W. and Sun, J. (2014) Cancer mortality in Inner Mongolia of China, 2008-2010. Open Journal of Epidemiology, 4, 14-18. doi: 10.4236/ojepi.2014.41003.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.